Foster City, CA, United States of America

Ramesh Baliga

USPTO Granted Patents = 26 (Patent Applications = 28)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 164(Granted Patents)

Location History:

Redwood City, CA (US) (2020 - 2023)
Foster city, CA (US) (2008 - 2024)

Company Filing History:

14 out of 20

Igm Biosciences, Inc.

patents

8 out of 52

Sutro Biopharma, Inc.

Years Active: 2008-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252552 - Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use (2025-03-18),

2. 11958909 - Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2024-04-16),

3. 11639389 - Binding molecules with modified J-chain (2023-05-02),

4. 11578131 - Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules (2023-02-14),

5. 11555075 - Modified J-chain (2023-01-17),

6. 11542342 - Binding molecules with modified J-chain (2023-01-03),

7. 11535664 - Multi-valent hepatitis B virus antigen binding molecules and uses thereof (2022-12-27),

8. 11401337 - Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function (2022-08-02),

9. 11344626 - Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2022-05-31),

10. 10975147 - Modified J-chain (2021-04-13),

11. 10954302 - Anti-PD-L1 antibodies (2021-03-23),

12. 10899835 - IgM Fc and J-chain mutations that affect IgM serum half-life (2021-01-26),

13. 10787520 - Multimeric bispecific binding molecules specific for CD20 and CD3 (2020-09-29),

14. 10689449 - Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof (2020-06-23),

15. 10669347 - Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2020-06-02),

Title: Innovations by Ramesh Baliga: A Pioneer in Biopharmaceutical Patents

Introduction: Ramesh Baliga is an accomplished inventor based in Foster City, CA, with an impressive portfolio of 25 patents. His work focuses on the development of novel antibodies and binding molecules that have significant implications in the fields of treatment, prevention, detection, and diagnosis of diseases.

Latest Patents: Among his latest contributions to the field are several groundbreaking patents. One patent includes antibodies comprising site-specific non-natural amino acid residues, along with methods for their preparation and use. These innovative antibodies present a new avenue for medical treatment and diagnostic procedures. Another notable patent features binding molecules with a modified J-chain, designed to include a binding moiety that antagonizes a T-cell inhibitory signaling pathway, expanding their utilization in therapeutic applications.

Career Highlights: Ramesh Baliga has significantly contributed to the biopharmaceutical industry through his work at renowned companies such as IgM Biosciences, Inc. and Sutro Biopharma, Inc. His extensive experience and expertise have equipped him to innovate in the complex area of antibody development.

Collaborations: Throughout his career, Ramesh has worked alongside distinguished colleagues, including Bruce Alan Keyt and Leonard G. Presta. These collaborations have been instrumental in advancing his research and enhancing the impact of his inventions in the scientific community.

Conclusion: Ramesh Baliga's dedication to innovation and his extensive portfolio of patents exemplify his significant contributions to biopharmaceutical research. His developments in antibodies and binding molecules are paving the way for future advancements in medical treatment and diagnostics, making him a notable figure in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.